The microbiome profiling business is the result of collaboration between two former Roche employees and researchers from UConn and Yale New Haven Hospital.
Shoreline Biome, a US-based microbiome profiling technology developer based at University of Connecticut’s Technology Incubation Program, has raised $1.1m in funding from investors including state-owned VC firm Connecticut Innovations.
A range of unnamed, private investors also contributed to the funding round.
Founded in 2015, Shoreline Biome develops kits, protocols and software that evaluate microorganisms in the human microbiome, a network of microbial cells such as bacteria, fungi and viruses.
High-resolution microbiome profiling has been linked to improving the diagnostic outlook…
